These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37951244)

  • 1. Antibiotics used to treat acne may be associated with inflammatory bowel disease: Response to Kridin et al "Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study".
    Lin CY; Yao CA
    J Am Acad Dermatol; 2024 Apr; 90(4):e135-e136. PubMed ID: 37951244
    [No Abstract]   [Full Text] [Related]  

  • 2. Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study.
    Kridin K; Ludwig RJ
    J Am Acad Dermatol; 2023 Apr; 88(4):824-830. PubMed ID: 36529376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin is not associated with inflammatory bowel disease even when compared with topical antibiotics and topical retinoids.
    Kridin K; Ludwig RJ
    J Am Acad Dermatol; 2024 Apr; 90(4):e137-e138. PubMed ID: 37951246
    [No Abstract]   [Full Text] [Related]  

  • 4. A propensity score matched cohort study identifying an association of acne, but not oral antibiotic or isotretinoin use, with risk of incident inflammatory bowel disease.
    Taylor MT; Margolis DJ; Kwatra SG; Barbieri JS
    J Am Acad Dermatol; 2023 Apr; 88(4):841-847. PubMed ID: 36682724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin and risk of inflammatory bowel disease: More data to support lack of meaningful risk.
    Barbieri JS
    J Am Acad Dermatol; 2021 Jan; 84(1):228-229. PubMed ID: 32682880
    [No Abstract]   [Full Text] [Related]  

  • 6. Acne treatment and inflammatory bowel disease: what is the evidence?
    Alikhan A; Henderson GP; Becker L; Sciallis GF
    J Am Acad Dermatol; 2011 Sep; 65(3):650-654. PubMed ID: 21704420
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.
    Margolis DJ; Fanelli M; Hoffstad O; Lewis JD
    Am J Gastroenterol; 2010 Dec; 105(12):2610-6. PubMed ID: 20700115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotretinoin and intestinal inflammation: what gastroenterologists need to know.
    Shale M; Kaplan GG; Panaccione R; Ghosh S
    Gut; 2009 Jun; 58(6):737-41. PubMed ID: 19433589
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease.
    Femia AN; Ann Vleugels R
    J Invest Dermatol; 2013 Apr; 133(4):866-8. PubMed ID: 23486427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis.
    Lee SY; Jamal MM; Nguyen ET; Bechtold ML; Nguyen DL
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):210-6. PubMed ID: 26545085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of isotretinoin on inflammatory bowel disease flare in patients with preexisting inflammatory bowel disease diagnosis: A cross-sectional study.
    Lopez CG; Kwak R; McCormack L; Zhou G; Charrow A
    J Am Acad Dermatol; 2022 Dec; 87(6):1399-1400. PubMed ID: 35597387
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of severe acne with isotretinoin in patients with inflammatory bowel disease.
    Godfrey KM; James MP
    Br J Dermatol; 1990 Nov; 123(5):653-5. PubMed ID: 2147391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roaccutane and inflammatory bowel disease].
    Pettersson U; Mjorndal T
    Lakartidningen; 2006 Dec; 103(50-52):4047. PubMed ID: 17330604
    [No Abstract]   [Full Text] [Related]  

  • 14. Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease".
    Mostow EN
    Arch Dermatol; 2011 Jun; 147(6):729-30. PubMed ID: 21690538
    [No Abstract]   [Full Text] [Related]  

  • 15. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.
    Crockett SD; Porter CQ; Martin CF; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2010 Sep; 105(9):1986-93. PubMed ID: 20354506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris.
    Reilly BK; Ritsema TS
    JAAPA; 2015 Jul; 28(7):34-9. PubMed ID: 26107793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.
    Alhusayen RO; Juurlink DN; Mamdani MM; Morrow RL; Shear NH; Dormuth CR;
    J Invest Dermatol; 2013 Apr; 133(4):907-12. PubMed ID: 23096714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotretinoin-induced inflammatory bowel disease in an adolescent.
    Reniers DE; Howard JM
    Ann Pharmacother; 2001 Oct; 35(10):1214-6. PubMed ID: 11675849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    Eur J Clin Pharmacol; 2013 Apr; 69(4):1041-2. PubMed ID: 23052415
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin.
    Wright S; Strunk A; Garg A
    J Am Acad Dermatol; 2021 Jan; 84(1):41-45. PubMed ID: 32682881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.